薬物スクリーニング検査サービスの世界市場2021年-2028年:種類別(職場薬物検査、臨床毒性検査)、検体タイプ別(尿、口腔液、髪の毛、その他)、エンドユーザー別(小売、石油&ガス、輸送、人員配置、政府、その他職場)、地域別

■ 英語タイトル:Drug Screening Laboratory Services Market by Type (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair, and Others), End Users (Retail, Oil & Gas, Transportation, Staffing, Government, and Other Workplaces), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021-2028

調査会社Research Dive社が発行したリサーチレポート(データ管理コード:RDV21SE017)■ 発行会社/調査会社:Research Dive
■ 商品コード:RDV21SE017
■ 発行日:2021年6月8日
■ 調査対象地域:グローバル
■ 産業分野:医薬品
■ ページ数:258
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール
■ 販売価格オプション(消費税別)
Single UserUSD5,700 ⇒換算¥843,600見積依頼/購入/質問フォーム
5 UserUSD8,700 ⇒換算¥1,287,600見積依頼/購入/質問フォーム
Enterprise UserUSD10,700 ⇒換算¥1,583,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Research Dive社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[薬物スクリーニング検査サービスの世界市場2021年-2028年:種類別(職場薬物検査、臨床毒性検査)、検体タイプ別(尿、口腔液、髪の毛、その他)、エンドユーザー別(小売、石油&ガス、輸送、人員配置、政府、その他職場)、地域別]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Research Dive社の本調査資料では、薬物スクリーニング検査サービスの世界市場について調査・分析し、調査手法、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症の影響、種類別(職場薬物検査、臨床毒性検査)分析、検体タイプ別(尿、口腔液、髪の毛、その他)分析、エンドユーザー別(小売、石油&ガス、輸送、人員配置、政府)分析、地域別分析、企業情報など、以下の構成でまとめております。
・調査手法
・エグゼクティブサマリー
・市場概要
・新型コロナウイルス感染症の影響
・薬物スクリーニング検査サービスの世界市場規模:種類別(職場薬物検査、臨床毒性検査)
・薬物スクリーニング検査サービスの世界市場規模:検体タイプ別(尿、口腔液、髪の毛、その他)
・薬物スクリーニング検査サービスの世界市場規模:エンドユーザー別(小売、石油&ガス、輸送、人員配置、政府)
・薬物スクリーニング検査サービスの世界市場規模:地域別
・企業情報

According to Research Dive analysis, the drug screening laboratory services market is estimated to generate a revenue of $10,951.4 million by 2028, increasing from $4,586.4 million in 2020, at a healthy CAGR of 12.8%.
Impact Analysis of COVID-19 on the Drug Screening Laboratory Services Market:
The drug screening laboratory services market experienced a decreased growth rate during the Covid-19 pandemic. Due to lockdown and transportation restrictions, the demand and supply of drug testing kits, equipments, reagents and analyzers have reduced due to which the drug testing is negatively affected. Also, high unemployment and migration rate has led to less number of technicians to operate the laboratory. Apart from this, many drug testing laboratories have been converted to COVID centers which has also impacted the market growth in the pandemic period.
Drug Screening Laboratory Services Analysis:
Increased consumption of drugs such as marijuana, cocaine, and others among the people is expected to drive the market of drug screening laboratory services. Millennials are more inclined towards drugs and alcohol as they find these habits cooler and the only way to fit in themselves with their friends. Also, drugs are the tools for them to stay calm and satisfied. Therefore, the people become drug addicts. This factor is expected to accelerate the market growth. Some companies also conduct drug test for their employees in order to monitor their health regularly is also expected to flourish the market of drug screening Laboratory Services in the forecast timeframe.
However, inclination of people towards a healthy lifestyle and will to stop consuming drugs will restrain the market growth.
Advances in technology and testing methods are expected to provide many opportunities for the manufacturing industries in the market. Continuous innovation and advancements in the testing methods used for drug testing and screening is expected to provide a boost to the growth of the market in the near future. Currently, urine, blood and hair sample is collected to test if the person has consumed drugs or is a drug addict. New technology introduction for drug testing is likely to save much time and is a hassle free method. For instance, as per the article published in ‘American Addiction Centers’ in February 2021, a new technology ‘paper spray mass spectrometry’ is developed to examine the molecules present in a fingerprint. As the person’s body metabolizes drugs, it excretes molecules with drug traces which can easily be detected in the fingerprints by using paper spray mass spectrometry. This innovation is anticipated to rise the market growth in the coming years.
Based on type, the market has been divided into workplace drug testing and clinical toxicology testing.
The workplace drug testing sub-segment shall have the fastest market growth and it is anticipated to generate a revenue of $8,635.50 million by 2028.
Based on sample type, the market is divided into urine, oral fluid, hair and others. The urine sub-segment garnered $3,647.40 million in 2020 and is projected to grow exponentially by 2028.
Based on the end users, the market is divided into retail, oil & gas, transportation, staffing, government and other workplace. The government sub-segment is predicted to be growing significantly and it is expected to cross $2,807.50 million by 2028.
Based on geographical scope, the market was investigated across North America, Europe, Asia-Pacific, and LAMEA. The Asia-Pacific market is anticipated to rise at a growth rate of 13.10% by 2028 from the revenue generated in 2020.
The companies involved in the drug screening laboratory services market are Abbott Laboratories, Quest Diagnostics, Clinical Reference Laboratory, Omega Laboratories, Inc., Laboratory Corporation of America Holdings, Cordant Health Solutions, Acm Global Laboratories, Millennium Health, Precision Diagnostics, and Psychemedics.

*** レポート目次(コンテンツ)***

CHAPTER 1:INTRODUCTION

1.1.Research methodology

1.1.1.Desk research
1.1.2.Real-time insights and validation
1.1.3.Forecast model
1.1.4.Assumptions & forecast parameters

1.1.4.1.Assumptions
1.1.4.2.Forecast parameters

CHAPTER 2:EXECUTIVE SUMMARY

2.1.360° summary
2.2.Type trends
2.3.Sample Type trends
2.4.End user trends

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key takeaways

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.2.2.1.Top winning strategies, by year
3.2.2.2.Top winning strategies, by development
3.2.2.3.Top winning strategies, by company

3.2.3.Top player positioning

3.3.Porter’s five forces analysis
3.4.Market dynamics
3.5.Drivers
3.6.Restraints
3.7.Opportunities
3.8.Technology landscape
3.9.Regulatory landscape
3.10.Market value chain analysis
3.11.Strategic overview

CHAPTER 4:IMPACT OF COVID19 ON DRUG SCREENING LABORATORY SERVICES MARKET

4.1.Introduction

4.2.COVID-19 health assessment
4.3.Impact of COVID-19 on the global economy
4.4.Impact of COVID-19 on global drug screening laboratory services market

4.4.1.Technological impact
4.4.2.Investment scenario

4.5.Drug screening laboratory services market size and forecast, by region, 2020-2028

CHAPTER 5:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET, BY TYPE

5.1.Overview

5.1.1.Market size and forecast, by type

5.2.Workplace drug testing

5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country

5.3.Clinical toxicological testing

5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country

CHAPTER 6:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE

6.1.Overview

6.1.1.Market size and forecast, by sample type

6.2.Urine

6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market share analysis, by country

6.3.Oral fluid

6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market share analysis, by country

6.4.Hair

6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market share analysis, by country

6.5.Others

6.5.1.Key market trends, growth factors and opportunities
6.5.2.Market size and forecast, by region
6.5.3.Market share analysis, by country

CHAPTER 7:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET BY END USER

7.1.Overview

7.1.1.Market size and forecast, by type

7.2.Retail

7.2.1.Key market trends, growth factors and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market share analysis, by country

7.3.Oil & Gas

7.3.1.Key market trends, growth factors and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market share analysis, by country

7.4.Transportation

7.4.1.Key market trends, growth factors and opportunities
7.4.2.Market size and forecast, by region
7.4.3.Market share analysis, by country

7.5.Staffing

7.5.1.Key market trends, growth factors and opportunities
7.5.2.Market size and forecast, by region
7.5.3.Market share analysis, by country

7.6.Government

7.6.1.Key market trends, growth factors and opportunities
7.6.2.Market size and forecast, by region
7.6.3.Market share analysis, by country

7.7.Other workplaces

7.7.1.Key market trends, growth factors and opportunities
7.7.2.Market size and forecast, by region
7.7.3.Market share analysis, by country

CHAPTER 8:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast, by region

8.2.North America

8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by type
8.2.3.Market size and forecast, by sample type
8.2.4.Market size and forecast, by end-user
8.2.5.Market size and forecast, by country

8.2.6.U.S.

8.2.6.1.Market size and forecast, by type
8.2.6.2.Market size and forecast, by sample type
8.2.6.3.Market size and forecast, by end-user

8.2.7.Canada

8.2.7.1.Market size and forecast, by type
8.2.7.2.Market size and forecast, by sample type
8.2.7.3.Market size and forecast, by end user

8.2.8.Mexico

8.2.8.1.Market size and forecast, by type
8.2.8.2.Market size and forecast, by sample type
8.2.8.3.Market size and forecast, by end user

8.3.Europe

8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by type
8.3.3.Market size and forecast, by sample type
8.3.4.Market size and forecast, by end-user
8.3.5.Market size and forecast, by country

8.3.6.Germany

8.3.6.1.Market size and forecast, by type
8.3.6.2.Market size and forecast, by sample type
8.3.6.3.Market size and forecast, by end user

8.3.7.UK

8.3.7.1.Market size and forecast, by type
8.3.7.2.Market size and forecast, by sample type
8.3.7.3.Market size and forecast, by end user

8.3.8.France

8.3.8.1.Market size and forecast, by type
8.3.8.2.Market size and forecast, by sample type
8.3.8.3.Market size and forecast, by end user

8.3.9.Italy

8.3.9.1.Market size and forecast, by type
8.3.9.2.Market size and forecast, by sample type
8.3.9.3.Market size and forecast, by end user

8.3.10.Spain

8.3.10.1.Market size and forecast, by type
8.3.10.2.Market size and forecast, by sample type
8.3.10.3.Market size and forecast, by end user

8.3.11.Rest of Europe

8.3.11.1.Market size and forecast, by type
8.3.11.2.Market size and forecast, by sample type
8.3.11.3.Market size and forecast, by end user

8.4.Asia-Pacific

8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by type
8.4.3.Market size and forecast, by sample type
8.4.4.Market size and forecast, by end user
8.4.5.Market size and forecast, by country

8.4.6.China

8.4.6.1.Market size and forecast, by type
8.4.6.2.Market size and forecast, by sample type
8.4.6.3.Market size and forecast, by end user

8.4.7.Japan

8.4.7.1.Market size and forecast, by type
8.4.7.2.Market size and forecast, by sample type
8.4.7.3.Market size and forecast, by end user

8.4.8.Australia

8.4.8.1.Market size and forecast, by type
8.4.8.2.Market size and forecast, by sample type
8.4.8.3.Market size and forecast, by end user

8.4.9.South Korea

8.4.9.1.Market size and forecast, by type
8.4.9.2.Market size and forecast, by sample type
8.4.9.3.Market size and forecast, by end user

8.4.10.India

8.4.10.1.Market size and forecast, by type
8.4.10.2.Market size and forecast, by sample type
8.4.10.3.Market size and forecast, by end user

8.4.11.Rest of Asia-Pacific

8.4.11.1.Market size and forecast, by type
8.4.11.2.Market size and forecast, by sample type
8.4.11.3.Market size and forecast, by end user

8.5.LAMEA

8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by type
8.5.3.Market size and forecast, by sample type
8.5.4.Market size and forecast, by end user
8.5.5.Market size and forecast, by country

8.5.6.Latin America

8.5.6.1.Market size and forecast, by type
8.5.6.2.Market size and forecast, by sample type
8.5.6.3.Market size and forecast, by end user

8.5.7.Middle East

8.5.7.1.Market size and forecast, by type
8.5.7.2.Market size and forecast, by sample type
8.5.7.3.Market size and forecast, by end user

8.5.8.Africa

8.5.8.1.Market size and forecast, by type
8.5.8.2.Market size and forecast, by sample type
8.5.8.3.Market size and forecast, by end user

CHAPTER 9:COMPANY PROFILES

9.1.Abbott Laboratories

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments

9.2.Quest Diagnostics

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments

9.3.Clinical Reference Laboratory, Inc

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Product portfolio
9.3.4.Key strategic moves and developments

9.4.Laboratory Corporation of America Holdings

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business Segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments

9.5.Cordant Health Solutions

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Product portfolio
9.5.4.Key strategic moves and developments

9.6.Psychemedics Corporation

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Product portfolio
9.6.4.Business performance
9.6.5.Key strategic moves and developments

9.7.ACM Global Laboratories

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Product portfolio
9.7.4.Key strategic moves and development

9.8.Omega Laboratories

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Product portfolio
9.8.4.Key strategic moves and developments

9.9.Millennium Health

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Product portfolio
9.9.4.Key strategic moves and developments

9.10.Precision Diagnostics

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Product portfolio



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(RDV21SE017 )"薬物スクリーニング検査サービスの世界市場2021年-2028年:種類別(職場薬物検査、臨床毒性検査)、検体タイプ別(尿、口腔液、髪の毛、その他)、エンドユーザー別(小売、石油&ガス、輸送、人員配置、政府、その他職場)、地域別" (英文:Drug Screening Laboratory Services Market by Type (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair, and Others), End Users (Retail, Oil & Gas, Transportation, Staffing, Government, and Other Workplaces), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021-2028)はResearch Dive社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。